logo
Select company
Select metric
$ -1.17MEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)
VS
Market
33
Sector
72
Industry
88
History
100
$ 3.04Close
$ 1.41 - $ 15.24 52-Week Range
Ticker Information

Ticker

VIVS

Company Name

VIVOSIM LABS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

VIVOSIM LABS INC - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

VIVS - EBITDA Historical data
DateDepreciation, Amortization & AccretionEarning Before Interest & Taxes (EBIT)Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)
6/30/2025$ 801K$ -1.97M$ -1.17M
3/31/2025$ 698K$ -2.48M$ -1.78M
12/31/2024$ 276K$ -12.38M$ -12.1M
9/30/2024$ 280K$ -12.54M$ -12.26M
6/30/2024$ 283K$ -13.98M$ -13.7M
3/31/2024$ 280K$ -14.67M$ -14.39M
12/31/2023$ 268K$ -19.08M$ -18.82M
9/30/2023$ 327K$ -18.74M$ -18.42M
6/30/2023$ 310K$ -18.07M$ -17.76M
3/31/2023$ 293K$ -17.26M$ -16.96M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • VIVOSIM LABS INC's latest trailing twelve months (TTM) EBITDA stands at $ -17.04M.
  • Over the past 5 years, VIVOSIM LABS INC's average EBITDA has been $ -13.21M.
  • The median EBITDA for VIVOSIM LABS INC during this period was $ -12.98M
  • VIVOSIM LABS INC reached its highest EBITDA over the past 5 years at $ -1.17M.
  • The lowest EBITDA recorded by VIVOSIM LABS INC in the same timeframe $ -18.82M

VIVOSIM LABS INC's EBITDA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA Benchmarks
CompanyEBITDA
AIM : AIM IMMUNOTECH INC $ -14.93MSILO : SILO PHARMA INC $ -4.88MGLTO : GALECTO INC $ -16.57MDRMA : DERMATA THERAPEUTICS INC $ -10.33MADTX : ADITXT INC $ -29.78MOGEN : ORAGENICS INC $ -9.51MHCWB : HCW BIOLOGICS INC $ -8.92MSLRX : SALARIUS PHARMACEUTICALS INC $ -5.1MTOVX : THERIVA BIOLOGICS INC $ -28.94MREVB : REVELATION BIOSCIENCES INC $ -8.43M

Similar metrics to EBITDA:

Definition of Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

[Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].
EBIT + DepAmor
(=) EBITDA EBITDA for VIVOSIM LABS INC is calculated as follows: EBIT [ $ -17.81M ] + DepAmor [ $ 771K ]
(=) EBITDA [ $ -17.04M ]

VIVS - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA), Last 5 years

$ -18.82M

Minimum

Dec 31, 2023

$ -1.17M

Maximum

Jun 30, 2025

$ -13.21M

Average

$ -12.98M

Median

EBITDA Benchmark Analysis

 The chart above depicts the distribution of EBITDA for companies in the Total Stock Market. The average EBITDA of the companies is $ 58.9M with a standard deviation of $ 167.01M.
The following table provides additional summary stats:
EBITDA in the Market:
filtered constituents3.24K
min$ -493.3M
max$ 590.6M
average$ 58.9M
median$ 8.92M
std$ 167.01M